Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Arvinas Inc.
ARVN
$
20.97
-5.6%
Wed August 19th, 2020
15:48
Analysis
ESSA's Novel Prostate Cancer Treatment In Clinical Trial: Pfizer Is New Lead Investor
Seeking Alpha
Mon August 17th, 2020
23:02
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
IPO
Analysis
IPO Update: Kymera Therapeutics Readies $125 Million IPO
Seeking Alpha
Tue August 4th, 2020
13:05
Analysis
Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue Estimates
Zacks
Mon July 27th, 2020
16:31
Earnings
Analysis
Earnings Preview: Arvinas, Inc. (ARVN) Q2 Earnings Expected to Decline
Zacks
Tue July 21st, 2020
19:55
IPO
Analysis
IPO Update: Nurix Therapeutics Prepares IPO Terms
Seeking Alpha
Wed July 8th, 2020
19:01
IPO
Analysis
Nurix Therapeutics Files For U.S. IPO
Seeking Alpha
Fri June 12th, 2020
20:42
Analysis
Arvinas (ARVN) Investor Presentation - Slideshow
Seeking Alpha
Fri June 5th, 2020
16:00
Rating
Analysis
Arvinas, Inc. (ARVN) Upgraded to Buy: Here's Why
Zacks
Fri May 22nd, 2020
14:22
Screening For The Best Growth Stocks
Seeking Alpha
